Erenumab (anti-CALCRL)，1582205
-90-0，ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot，阿拉丁- ￥579.90 - 11799.90
- 阿拉丁
- 上海
- Ab170518
- 2025年07月08日
企业认证
相关产品推荐更多 >
Gemtuzumab (anti-CD33)，220578-59-6，ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot，阿拉丁
￥649.90(+)-Columbianetin acetate，23180-65-6，≥99%，阿拉丁
￥1190.90Zolbetuximab (anti-CLDN18.2)，1496553-00-4，ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot，阿拉丁
￥549.90AG-024322，837364-57-5，≥98%，阿拉丁
￥6000.90PD-1/PD-L1-IN-9，2628506-54-5，阿拉丁
￥3500.90
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
-80℃储存;避免反复冻融
- 英文名：
Erenumab (anti-CALCRL)
- 库存：
现货
- 供应商：
上海阿拉丁生化科技股份有限公司
- CAS号：
1582205-90-0
- 规格：
Ab170518-5mg/Ab170518-1mg/Ab170518-10mg/Ab170518-100μg
| 规格： | Ab170518-5mg | 产品价格： | ￥7299.9 |
|---|---|---|---|
| 规格： | Ab170518-1mg | 产品价格： | ￥2899.9 |
| 规格： | Ab170518-10mg | 产品价格： | ￥11799.9 |
| 规格： | Ab170518-100μg | 产品价格： | ￥579.9 |
Erenumab是一种全人单克隆抗体。Erenumab抑制降钙素基因相关肽（CGRP）受体。Erenumab 可用于预防发作性偏头痛。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验In situ hybridisation to alpha satellite sequences (chromosome specific)
; 100% ethanol 2 x 5 minutes, 90% Ethanol 5 minutes, 75% ethanol 5 minutes, H2 O 2 x 5 minutes and allow to dry. Store dry, dust-free. Typical Protocol (1) Immerse the slides in 1M sodium thiocyanate at 80C for 10 minutes. Rinse in H2 O and allow
In Situ Hybridization Using Digoxigenin Labeled Probes
and the attached fat body. If this does not occur, carefully dissect away the fat body 5) Transfer the "fat free" glands into the fixative and incubate for 4-5 minutes 6) Pick up the coverslip and glands with a clean slide by carefully touching the slide
Antigen Design Sera Purification Tech Sheet
will briefly explore peptide selection and design, coupling strategy, and carrier proteins which are important factors in anti-peptide antisera generation. Serum purification will also be discussed. For more complete coverage of antigen design, please refer
技术资料暂无技术资料 索取技术资料
